EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decline of phosphatidylethanol (B‐PEth) during abstinence in patients with alcohol use disorder undergoing withdrawal treatment, and the correlation of B‐PEth with self‐reported alcohol intake

Andrea de Bejczy iD, Lisa Walther, Cecilia Nilsson-Wallmark, Barbro Askerup, Anders Isaksson

Addiction · 2026

DOI: 10.1111/add.70359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, 2026. Verfasst von Andrea de Bejczy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Addiction Biology Unit, Psychiatry and Neurochemistry Section, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenbur…. Hauptthemen laut MEDLINE: Glycerophospholipids, Alcohol Drinking, Alcohol Abstinence, Alcoholism. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Västra Götaland ALF, Swedish State.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aim Accurately estimating alcohol consumption is crucial for clinical decision‐making and monitoring treatment outcomes. Phosphatidylethanol in blood (B‐PEth), a direct alcohol biomarker, is currently the most reliable indicator of alcohol intake, with a detection window of several weeks; however, the factors influencing the decline of B‐PEth levels remain largely unknown. This study aimed to investigate the decline of B‐PEth levels during abstinence in patients with alcohol use disorder (AUD) undergoing withdrawal treatment.

Method

A total of 100 patients were recruited in withdrawal treatment and followed during three to four weeks of abstinence. Blood samples were collected at baseline and weekly during abstinence to measure B‐PEth levels of two homologues (16:0/18:1 and 16:0/18:2). Self‐reported alcohol consumption was documented using the Timeline Followback (TLFB) method for 30 days before abstinence and throughout the study period.

Results

B‐PEth elimination followed first‐order kinetics. The mean half‐life was 7.24 days [95% confidence interval (CI) = 6.98–7.53] for 16:0/18:1 and 4.55 days (95% CI = 4.44–4.67) for 16:0/18:2. The rate of decline varied by week, with a longer half‐life observed in week three compared with week one. No statistically significant sex differences were detected. The strongest correlation between B‐PEth levels and self‐reported alcohol consumption was found for data from two weeks prior to abstinence.

Conclusion

Elimination of phosphatidylethanol in blood (B‐Peth) follows first‐order kinetics, with homologue 16:0/18:1 exhibiting a longer half‐life than 16:0/18:2. The rate of decline is influenced by the week of alcohol abstinence and B‐PEth levels are detectable even in the fourth week of abstinence. The strongest correlation between B‐PEth and self‐reported alcohol consumption is at two weeks prior to abstinence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycerophospholipidsAlcohol DrinkingAlcohol AbstinenceAlcoholismSubstance Withdrawal SyndromeHumansMaleFemaleBiomarkersSelf ReportAdultMiddle Aged

Stichwörter der Autor:innen

abstinencealcoholalcohol biomarkeralcohol use disorder (AUD)alcohol withdrawaldeclineeliminationhalf‐lifephosphatidylethanol (B‐PEth)

Substanzen

GlycerophospholipidsphosphatidylethanolBiomarkers

Autor:innen und Institutionen

  • Addiction Biology Unit, Psychiatry and Neurochemistry Section, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden.
  • Department of Addictions and Dependency, Sahlgrenska University Hospital, Sweden.
  • Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Department of Clinical Chemistry and Pharmacology, Skåne University Hospital, Lund, Sweden.

ORCID-Profile: Andrea de Bejczy

Förderung

  • Region Västra Götaland ALF
  • Swedish State

Zitieren

APA

de Bejczy, A., Walther, L., Nilsson-Wallmark, C., Askerup, B., & Isaksson, A. (2026). Decline of phosphatidylethanol (B‐PEth) during abstinence in patients with alcohol use disorder undergoing withdrawal treatment, and the correlation of B‐PEth with self‐reported alcohol intake. Addiction. https://doi.org/10.1111/add.70359

Vancouver

de Bejczy A, Walther L, Nilsson-Wallmark C, Askerup B, Isaksson A. Decline of phosphatidylethanol (B‐PEth) during abstinence in patients with alcohol use disorder undergoing withdrawal treatment, and the correlation of B‐PEth with self‐reported alcohol intake. Addiction. 2026. doi:10.1111/add.70359

BibTeX
@article{deBejczy2026,
  author = {de Bejczy, Andrea and Walther, Lisa and Nilsson-Wallmark, Cecilia and Askerup, Barbro and Isaksson, Anders},
  title = {Decline of phosphatidylethanol (B‐PEth) during abstinence in patients with alcohol use disorder undergoing withdrawal treatment, and the correlation of B‐PEth with self‐reported alcohol intake},
  journal = {Addiction},
  year = {2026},
  doi = {10.1111/add.70359}
}
Kostenlos starten →